tiprankstipranks
Trending News
More News >
Lipocine Inc (LPCN)
NASDAQ:LPCN
US Market

Lipocine (LPCN) Income Statement

Compare
919 Followers

Lipocine Income Statement

Last quarter (Q4 2025), Lipocine's total revenue was $1.15M, a decrease of -67.19% from the same quarter last year. In Q4, Lipocine's net income was $-2.37M. See Lipocine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.98M$ 11.20M$ -2.85M$ 500.00K$ 16.14M
Gross Profit
$ 1.92M$ 11.20M$ -13.03M$ -8.06M$ 8.48M
Operating Expenses
$ 12.35M$ 12.35M$ 4.90M$ 4.06M$ 5.33M
Depreciation and Amortization
$ 60.78K$ 41.11K$ 28.66K$ 9.45K$ 380.00
EBITDA
$ -10.31M$ -1.11M$ -17.90M$ -10.72M$ -430.53K
Operating Income
$ -10.37M$ -1.16M$ -17.93M$ -12.12M$ 3.15M
Other Income/Expenses
$ 744.07K$ 1.16M$ 1.58M$ 1.36M$ -3.78M
Pretax Income
$ -9.63M$ 9.03K$ -16.35M$ -10.76M$ -634.20K
Net Income
$ -9.63M$ 8.35K$ -16.35M$ -10.76M$ -634.40K
Per Share Metrics
Basic EPS
$ -1.77$ 0.00$ -3.14$ -2.15$ -0.19
Diluted EPS
$ -1.69$ 0.00$ -3.14$ -2.05$ -0.12
Weighted Average Shares Outstanding
5.45M 5.34M 5.27M 4.99M 3.30M
Weighted Average Shares Outstanding (Diluted)
5.71M 5.42M 5.27M 5.26M 5.15M
Currency in USD

Lipocine Earnings and Revenue History